The case takes aim at the major pharmacy benefit managers, agency officials said, claiming that they favored more expensive insulin products and forced patients to pay more.
Related Posts
South Africa Built a Medical Research Powerhouse. Trump Cuts Have Demolished It.
The budget cuts threaten global progress on everything from heart disease to H.I.V. — and could affect American drug companies,…
Ninja, Twitch’s Top Streamer, Reveals Skin Cancer Diagnosis
Tyler Blevins, the video game superstar known as Ninja, revealed this week that he had been diagnosed with melanoma, a…
When My Mom Got Sick, This TV Show Kept Us Going
Every family has its archetypes, so here’s mine: My dad and my brother and I are all miserable. None of…